Home » Posts tagged with » Vaso-Occlusive Crisis
Novartis bags Adakveo FDA approval to reduce VOCs in sickle cell disease

Novartis bags Adakveo FDA approval to reduce VOCs in sickle cell disease

Adakveo FDA approval : Swiss drugmaker Novartis has bagged approval for Adakveo (crizanlizumab-tmca) from the US Food and Drug Administration (FDA) for its use in sickle cell disease. Formerly known as SEG101, Adakveo has been indicated to be used for bringing down the frequency of vaso-occlusive crises (VOCs), or pain crises, in patients, aged 16 […]

November 16, 2019No CommentRead More

RESET clinical trial results : Rivipansel flops in phase 3 trial in SCD

August 3, 2019 No Comment
RESET clinical trial results : Rivipansel flops in phase 3 trial in SCD

RESET clinical trial results : US pharma giant Pfizer’s rivipansel failed to meet the primary and key secondary efficacy endpoints of a phase 3 trial called RESET in sickle cell disease (SCD). The aim of the RESET clinical trial was to assess the efficacy and safety of rivipansel in sickle cell disease patients, aged six […]

Continue reading …